Disclaimer :

The Competition DG makes the information provided by the notifying parties in section 1.2 of Form CO available to the public in order to increase transparency. This information has been prepared by the notifying parties under their sole responsibility, and its content in no way prejudges the view the Commission may take of the planned operation. Nor can the Commission be held responsible for any incorrect or misleading information contained therein.

SECTION 1.2

Description of the concentration

By virtue of the notified concentration, the investment fund EQT VIII (managed by EQT Fund Management) intends to acquire sole control over NSH and its subsidiaries.

EQT VIII was launched in 2018 with commitments of approximately EUR 10.75 billion. The fund seeks to make investments primarily in Northern Europe. EQT VIII is part of the EQT group of private equity funds.

NSH is a global skin care company headquartered in Lausanne, Switzerland. The company offers a range of medical and consumer skin health solutions through three business units: Aesthetics, Prescription, and Consumer.

Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË

Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.